Apollomics (APLM) vs Pliant Therapeutics (PLRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Apollomics (APLM) has outperformed Pliant Therapeutics (PLRX) over the past year, gaining 16.6% versus a loss of 33.1%. Apollomics is the larger company by market cap ($62.7 million vs $61.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | APLM | PLRX |
|---|---|---|
| Share price | $21.50 | $0.99 |
| Market cap | $62.67M | $61.30M |
| 1-day change | -2.71% | -3.88% |
| YTD return | +15.00% | -18.85% |
| 1-year return | +16.64% | -33.11% |
| 5-year return | — | -94.50% |
| EPS (TTM) | $-7.57 | $-1.50 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $42.12 | $1.95 |
| 52-week low | $10.01 | $0.97 |
| Distance from 52-week high | -48.96% | -49.23% |
| Average volume | 21.85K | 488.25K |
| Shares outstanding | 2.91M | 61.92M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- APLM has outperformed PLRX by 49.7 percentage points over the past year.
APLM vs PLRX FAQ
Which is bigger, Apollomics or Pliant Therapeutics?
Apollomics (APLM) is larger, with a market capitalization of $62.67M compared with $61.30M for Pliant Therapeutics (PLRX).
Which stock has performed better over the past year, APLM or PLRX?
APLM returned +16.64% over the past 12 months, compared with -33.11% for PLRX (price return, excluding dividends). Past performance does not predict future results.
Are Apollomics and Pliant Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.